Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
10.31
+0.17 (1.73%)
At close: Jan 29, 2026, 4:00 PM EST
10.31
+0.01 (0.05%)
After-hours: Jan 29, 2026, 4:00 PM EST
Erasca Employees
Erasca had 103 employees as of December 31, 2024. The number of employees decreased by 23 or -18.25% compared to the previous year.
Employees
103
Change (1Y)
-23
Growth (1Y)
-18.25%
Revenue / Employee
n/a
Profits / Employee
-$1,239,670
Market Cap
3.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | 21 | 20.59% |
| Jun 30, 2021 | 102 | - | - |
| Mar 31, 2021 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| Denali Therapeutics | 517 |
| Arcutis Biotherapeutics | 342 |
| Xenon Pharmaceuticals | 327 |
| Vera Therapeutics | 224 |
| Alumis | 223 |
| Catalyst Pharmaceuticals | 181 |
| Viridian Therapeutics | 143 |
ERAS News
- 3 days ago - Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? - Benzinga
- 6 days ago - Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 days ago - Erasca Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewsWire
- 9 days ago - Erasca Announces Proposed Public Offering of $150 Million of Common Stock - GlobeNewsWire
- 17 days ago - Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones - GlobeNewsWire
- 21 days ago - What's Going With Cancer Biotech Erasca Stock On Thursday? - Benzinga
- 23 days ago - Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Erasca to Present at the 8th Annual Evercore Healthcare Conference - GlobeNewsWire